Eric Easom

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ANTX

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	AN2 Therapeutics, Inc. (ANTX)	President, Chief Executive Officer and Board Chair	$603,750	—	$164,133	$275,539	$332,063	$7,500	$1,382,985
2024	AN2 Therapeutics, Inc. (ANTX)	President, Chief Executive Officer and Board Chair	$603,750	—	$297,000	$508,820	$249,047	$7,500	$1,666,117
2023	AN2 Therapeutics, Inc. (ANTX)	President, Chief Executive Officer and Board Chair	$575,000	—	—	$2,422,848	$345,000	—	$3,342,848
2022	AN2 Therapeutics, Inc. (ANTX)	President and Chief Executive Officer	$481,185	—	—	$2,767,815	$216,533	—	$3,465,533
2021	AN2 Therapeutics, Inc. (ANTX)	President, Chief Executive Officer and Director	$377,300	—	—	$1,190,689	$151,000	—	$1,718,989

No earnings-call appearances or filed executive changes recorded yet.